Uncategorized
Severities surge in Countrywide’s New York loans
admin | January 10, 2020
This document is intended for institutional investors and is not subject to all of the independence and disclosure standards applicable to debt research reports prepared for retail investors. This material does not constitute research.
New York loans liquidated out of legacy Countrywide deals have often shown losses far greater than the balance of the loan. Low property values and hefty servicer advances that need to get repaid often add up to outsized losses. But there may be more at play in a recent spate of liquidations.
Among legacy loans from New York that left private MBS trusts in December with greater than a 100% loss severity, a disproportionate amount of came from Countrywide trusts. Countrywide liquidations totaled slightly more than $22 million with an average loss severity of 188% while New York loans liquidated in the rest of the legacy universe totaled just $6.2 million with an average severity of 135% (Exhibit 1)
Exhibit 1: Stacking up legacy NY liquidations in December
Source: Amherst Insight Labs, Amherst Pierpont Securities
New York loans leaving Countrywide trusts through liquidation over the past six months show a similar pattern. Since July, more than$44 million in principal balance liquidated with an average loss severity of roughly 170% across the CWALT, CWHL and CWL shelves. High loss severities in Countrywide loans show up with some frequency, especially in judicial states like New York where liquidation timelines are longer. However a closer analysis of some of these loans raises questions as to why these loss severities are so elevated.
Case study: CWHL 2005-21
In December, loan ID 94556757 left CWHL 2005-21 through foreclosure generating a 302% loss severity. Based on proprietary property matching, the loan looks secured by 1639 East 4 Street, Brooklyn, New York. The loan had a principal balance of $367,081 when it left the trust. Estimated total advances of principal, interest, and taxes come in at just less than $400,000. Additionally, the estimated value of the property runs in excess of $1 million.
There should have been adequate proceeds to not only compensate the servicer for advances but to pay off the balance of the loan in the case of liquidation. According to the Bank of NY December remittance report, however, there were zero liquidation proceeds and a negative subsequent recovery of over $740,500 on the loan, generating the greater than 300% loss severity. An analysis of court records on the property shows that not only was the property not liquidated, but that it still appears to be in active litigation.
Court records in King’s County Supreme Court Index Number 507339/2018 for November 14 show that not only has the property not been liquidated but BNY Mellon as trustee had chosen to discontinue the foreclosure action at that time. Additionally, the court ordered that the plaintiff BNY Mellon “withdraws its prior demand for immediate payment in full of all sums secured, and reinstitutes the Loan as an Installment Loan.”
This leads to two questions: why was the loan disposed of from the trust in December if there was in fact no liquidation and additionally, given the order is to return the loan to a monthly principal and interest installment loan, who is entitled to any principal and interest paid since the loan is no longer an asset of the trust? If the loan was charged off due to an inability to foreclose this example may be representative of a potentially larger issue in judicial foreclosure states with a statute of limitations on foreclosure actions.
Potential exposure
It’s difficult to say with certainty what the exposure may be for a couple of reasons. First, there is no absolute cap on what the loss severity on a given loan can be as it is a function of what the recovery, if any, on the property is plus any costs incurred in liquidation as well as advances that need to be reimbursed to the servicer. In the case where there is a charge-off or expungement of the lien, there is no potential recovery of principal and the trust incurs any additional losses associated with servicer reimbursement. Additionally, according to the terms of the Countrywide RMBS settlement, loans deemed ‘high risk’ are transferred to special servicing with each trust having a specific special servicer assigned to it. Different special servicers may be handling New York loans in foreclosure differently and potential charge-offs associated with the statute of limitations on foreclosures may not be uniform across all special servicers. Adding additional complexity, subsequent to the settlement, one of the six initially named servicers, RCS, is out of business, and information about where that special servicing was transferred is difficult to ascertain.
Exhibit 2: Certain Countrywide trusts have large concentrations of foreclosed loans in NY
Source: Amherst Insight Labs, Amherst Pierpont Securities
It seems reasonable that trusts with outsized exposure to foreclosure in New York may be subject to greater percentage risk of losses. Trusts with the largest concentrations of New York foreclosures tend to be relatively small, so, while it’s hard to cap potential exposure at the loan level, absolute losses likely appear to be limited. That being said most of the deals with outsized exposure were originally special serviced by RCS so it’s difficult to know where that special servicing resides and what the potential charge off risk associated with a statute of limitations on foreclosure may be. (Exhibit 2). At a minimum, until these outsized severity prints begin to abate, mezzanine bonds with large concentrations of delinquent or defaulted loans in New York should price substantially wider to account for the risk.
This material is intended only for institutional investors and does not carry all of the independence and disclosure standards of retail debt research reports. In the preparation of this material, the author may have consulted or otherwise discussed the matters referenced herein with one or more of SCM’s trading desks, any of which may have accumulated or otherwise taken a position, long or short, in any of the financial instruments discussed in or related to this material. Further, SCM may act as a market maker or principal dealer and may have proprietary interests that differ or conflict with the recipient hereof, in connection with any financial instrument discussed in or related to this material.
This message, including any attachments or links contained herein, is subject to important disclaimers, conditions, and disclosures regarding Electronic Communications, which you can find at https://portfolio-strategy.apsec.com/sancap-disclaimers-and-disclosures.
Important Disclaimers
Copyright © 2025 Santander US Capital Markets LLC and its affiliates (“SCM”). All rights reserved. SCM is a member of FINRA and SIPC. This material is intended for limited distribution to institutions only and is not publicly available. Any unauthorized use or disclosure is prohibited.
In making this material available, SCM (i) is not providing any advice to the recipient, including, without limitation, any advice as to investment, legal, accounting, tax and financial matters, (ii) is not acting as an advisor or fiduciary in respect of the recipient, (iii) is not making any predictions or projections and (iv) intends that any recipient to which SCM has provided this material is an “institutional investor” (as defined under applicable law and regulation, including FINRA Rule 4512 and that this material will not be disseminated, in whole or part, to any third party by the recipient.
The author of this material is an economist, desk strategist or trader. In the preparation of this material, the author may have consulted or otherwise discussed the matters referenced herein with one or more of SCM’s trading desks, any of which may have accumulated or otherwise taken a position, long or short, in any of the financial instruments discussed in or related to this material. Further, SCM or any of its affiliates may act as a market maker or principal dealer and may have proprietary interests that differ or conflict with the recipient hereof, in connection with any financial instrument discussed in or related to this material.
This material (i) has been prepared for information purposes only and does not constitute a solicitation or an offer to buy or sell any securities, related investments or other financial instruments, (ii) is neither research, a “research report” as commonly understood under the securities laws and regulations promulgated thereunder nor the product of a research department, (iii) or parts thereof may have been obtained from various sources, the reliability of which has not been verified and cannot be guaranteed by SCM, (iv) should not be reproduced or disclosed to any other person, without SCM’s prior consent and (v) is not intended for distribution in any jurisdiction in which its distribution would be prohibited.
In connection with this material, SCM (i) makes no representation or warranties as to the appropriateness or reliance for use in any transaction or as to the permissibility or legality of any financial instrument in any jurisdiction, (ii) believes the information in this material to be reliable, has not independently verified such information and makes no representation, express or implied, with regard to the accuracy or completeness of such information, (iii) accepts no responsibility or liability as to any reliance placed, or investment decision made, on the basis of such information by the recipient and (iv) does not undertake, and disclaims any duty to undertake, to update or to revise the information contained in this material.
Unless otherwise stated, the views, opinions, forecasts, valuations, or estimates contained in this material are those solely of the author, as of the date of publication of this material, and are subject to change without notice. The recipient of this material should make an independent evaluation of this information and make such other investigations as the recipient considers necessary (including obtaining independent financial advice), before transacting in any financial market or instrument discussed in or related to this material.
Important disclaimers for clients in the EU and UK
This publication has been prepared by Trading Desk Strategists within the Sales and Trading functions of Santander US Capital Markets LLC (“SanCap”), the US registered broker-dealer of Santander Corporate & Investment Banking. This communication is distributed in the EEA by Banco Santander S.A., a credit institution registered in Spain and authorised and regulated by the Bank of Spain and the CNMV. Any EEA recipient of this communication that would like to affect any transaction in any security or issuer discussed herein should do so with Banco Santander S.A. or any of its affiliates (together “Santander”). This communication has been distributed in the UK by Banco Santander, S.A.’s London branch, authorised by the Bank of Spain and subject to regulatory oversight on certain matters by the Financial Conduct Authority (FCA) and the Prudential Regulation Authority (PRA).
The publication is intended for exclusive use for Professional Clients and Eligible Counterparties as defined by MiFID II and is not intended for use by retail customers or for any persons or entities in any jurisdictions or country where such distribution or use would be contrary to local law or regulation.
This material is not a product of Santander´s Research Team and does not constitute independent investment research. This is a marketing communication and may contain ¨investment recommendations¨ as defined by the Market Abuse Regulation 596/2014 ("MAR"). This publication has not been prepared in accordance with legal requirements designed to promote the independence of research and is not subject to any prohibition on dealing ahead of the dissemination of investment research. The author, date and time of the production of this publication are as indicated herein.
This publication does not constitute investment advice and may not be relied upon to form an investment decision, nor should it be construed as any offer to sell or issue or invitation to purchase, acquire or subscribe for any instruments referred herein. The publication has been prepared in good faith and based on information Santander considers reliable as of the date of publication, but Santander does not guarantee or represent, express or implied, that such information is accurate or complete. All estimates, forecasts and opinions are current as at the date of this publication and are subject to change without notice. Unless otherwise indicated, Santander does not intend to update this publication. The views and commentary in this publication may not be objective or independent of the interests of the Trading and Sales functions of Santander, who may be active participants in the markets, investments or strategies referred to herein and/or may receive compensation from investment banking and non-investment banking services from entities mentioned herein. Santander may trade as principal, make a market or hold positions in instruments (or related derivatives) and/or hold financial interest in entities discussed herein. Santander may provide market commentary or trading strategies to other clients or engage in transactions which may differ from views expressed herein. Santander may have acted upon the contents of this publication prior to you having received it.
This publication is intended for the exclusive use of the recipient and must not be reproduced, redistributed or transmitted, in whole or in part, without Santander’s consent. The recipient agrees to keep confidential at all times information contained herein.
